Learn more

NINGBO BEAUTIFUL LIFE PHARMACEUTICAL BIOLOGICAL TECH DEV CO LTD

Overview
  • Total Patents
    13
  • GoodIP Patent Rank
    127,657
About

NINGBO BEAUTIFUL LIFE PHARMACEUTICAL BIOLOGICAL TECH DEV CO LTD has a total of 13 patent applications. Its first patent ever was published in 2014. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are NANJING PRACTICE MEDICINE EXAMINATION CO LTD, INST ANIMAL HUSBANDRY & VETERINARY FUJIAN ACAD AGRICULTURAL SCIENCES and SHANGHAI TISSUEBANK BIOTECHNOLOGY CO LTD.

Patent filings in countries

World map showing NINGBO BEAUTIFUL LIFE PHARMACEUTICAL BIOLOGICAL TECH DEV CO LTDs patent filings in countries
# Country Total Patents
#1 China 13

Patent filings per year

Chart showing NINGBO BEAUTIFUL LIFE PHARMACEUTICAL BIOLOGICAL TECH DEV CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Tian Xiaoli 13
#2 Li Weidong 3

Latest patents

Publication Filing date Title
CN106798931A Cav2.1 passages are mutated and Ca2+The growth rate relation of concentration
CN106798933A Reduce the increased speed influence Ca of calcium ionVThe degree of penumbra neuron reduction cell death in 2.1 mutant mouse models
CN106798928A Cav2.1 passages are in Ca2+The important function played in the ischaemic model of dependence
CN106798929A 2 kinds of mutant mice MODEL C avThe mutation of the subunit of 2.1 channel α 1 can slow down OGD inductions [Ca2+] i growth
CN106798930A CaVThe Infarction volume reduction in ischemia model in vivo of the mutant mouses of 2.1 α 1
CN106798926A CaVThe allelic mutations of 2.1 α 1 protect brain from ischemia injury
CN106798932A CavExpression of the subunit of 2.1 channel α 1 in wild-type mice, Rolling Nagoya and Leaner mice bodies
CN106801087A CavThe mRNA of 2.1 α 1 are in wild-type mice(n=6)、rolling Nagoya(n=5)With leaner mice(n=5)In expression pattern
CN106798927A CaV2.1 passages are in Ca2+The effect in brain tissue infarct size is adjusted in dependence ischemia model
CN106801088A Ca in Rolling Nagoya and Leaner mice mutant mice modeling brainsVThe foundation of the mutator detection of expression methods of 2.1 α 1
CN105670995A Application of RXR in construction of susceptibility model of murine gamma-herpes virus 68 (MHV68)
CN105670997A Application of RXR in screening of agonists of Ifnbeta, Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4
CN105670996A Application of RXR in construction of susceptibility model of herpes simplex virus type 1 (HSV-1)